Mars completes acquisition of Heska, global provider of advanced veterinary diagnostic and specialty solutions
Heska becomes part of Mars Petcare’s Science & Diagnostics division to broaden access to diagnostics and technology, accelerate R&D and innovation, and better serve more veterinary professionals and pets.
McLean, VA (June 13, 2023) — Mars, Incorporated (“Mars”) today announced the successful completion of Mars’ acquisition of Heska. On April 3, 2023, the companies announced they had entered into a definitive agreement under which Mars agreed to acquire Heska for $120.00 per share. Heska is now part of Mars Petcare’s Science & Diagnostics division, enabling broader coverage across diagnostics and technology, while accelerating R&D and expanding access globally to pet healthcare solutions.
Nefertiti Greene, President, Mars Science & Diagnostics, said: “It’s an honor to welcome Heska to the Science & Diagnostics division of Mars Petcare. Like us, Heska has grown into a purpose-driven business, supporting veterinary professionals globally. I am excited about what we can achieve with a full diagnostics portfolio across reference laboratories, point-of-care, imaging and technology solutions, rapid diagnostics, telemedicine and software solutions and services. We will continue to drive our R&D efforts to deliver innovative diagnostic solutions to help keep pets healthy, in service of our purpose: A Better World For Pets™.”
Advisors
Lazard served as Mars’ financial advisor, and Skadden, Arps, Slate, Meagher & Flom LLP acted as Mars’ legal advisor.
BofA Securities, Inc. and Piper Sandler & Co. served as Heska’s financial advisor, and Gibson, Dunn & Crutcher LLP acted as Heska’s legal advisor.
Media Contacts
Mars, Incorporated Media Inquiries:
Brunswick Group
Blake Sonnenshein/Sayagi Vallipuram
[email protected](Opens a new window) / [email protected](Opens a new window)